David B. Berger - May 27, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP, Chief Business/Compliance
Signature
s/ Karrie Rexford, Attorney-in-Fact for David B. Berger
Stock symbol
TNDM
Transactions as of
May 27, 2021
Transactions value $
-$354,575
Form type
4
Date filed
6/1/2021, 07:27 PM
Previous filing
May 20, 2021
Next filing
Aug 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +1.63K +33.44% $0.00 6.49K May 27, 2021 Direct
transaction TNDM Common Stock Tax liability -$58.3K -681 -10.5% $85.65 5.81K May 27, 2021 Direct F1
transaction TNDM Common Stock Options Exercise $16.7K +1.85K +31.93% $9.00 7.66K May 28, 2021 Direct F2
transaction TNDM Common Stock Sale -$160K -1.85K -24.2% $86.45 5.81K May 28, 2021 Direct
transaction TNDM Common Stock Sale -$153K -1.77K -30.39% $86.49 4.04K May 28, 2021 Direct
holding TNDM Common Stock 242 May 27, 2021 Berger Family Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -1.63K -25% $0.00 4.88K May 27, 2021 Common Stock 1.63K Direct F4, F5, F6, F7
transaction TNDM Stock Option Options Exercise $0 +1.85K $0.00* 0 May 28, 2021 Common Stock 1.85K $9.00 Direct F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2 Represents shares of common stock received upon exercise of a stock option award.
F3 The securities are held by the Berger Family Trust dated April 16, 2008.
F4 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
F5 Each RSU represents a contingent right to receive one share of common stock of the Company.
F6 This RSU award was granted on May 27, 2020. 25% of the RSU vested on May 27, 2021 and the remaining units shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.
F7 RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
F8 The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter.
F9 The expiration date for these options is 10 years from the date of grant.